inflammation; atherosclerose; ASCVD; IL-6; colchicine

Peter Libby presents the role of inflammation in ASCVD

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Exciting times to address residual inflammatory risk
Exciting times to address residual inflammatory risk
EAS 2024
Exciting times to address residual inflammatory risk
- Peter Libby, MD
Anti-inflammatory effects of GLP-1RA in T2D
Anti-inflammatory effects of GLP-1RA in T2D
EAS 2024
Anti-inflammatory effects of GLP-1RA in T2D
- Rein Oostveen, MD
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
ESC Congress 2023
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
- Stephen Nicholls, MD
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
ESC Congress 2023
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
- David Conen, MD